Cenix, IMM Collaborate on RNAi Screen for Malaria-Related Genes; Eye Full Human Genome | GenomeWeb

Building on a recently completed pilot study, Cenix BioScience and the Instituto de Medicina Molecular in Portugal are collaborating to identify human genes necessary for the malaria infection process, the groups said last week.

According to the partners, the effort is initially focused on more than 800 genes, but may be expanded to the entire human genome should IMM be able to secure sufficient funding. Should it do so, IMM hopes that Cenix's technology will allow it to identify the best targets for new malaria treatments.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: gene flow between ancient chimpanzees and bonobos, and more.

A startup wants to match customers to wine based on their DNA and one critic calls the idea 'silly,' Stat News reports.

Researchers trace the origins of brown rats using genetic analysis to China, the New York Times reports.

In Nature this week: genetic history of HIV in the US, and more.